ATP

The ATP Group is a privately owned asset management holding company based in Hillerød, Denmark, established in 1964. It operates as a self-governing institution, providing retirement and pension benefits, as well as managing pension funds for its clients. The firm’s services encompass pension, investment, hedging, and insurance activities, along with the administration of social security and welfare benefits on behalf of the Danish state and local authorities. ATP invests across various asset classes, including public and private equity, fixed income, and alternative markets globally. The organization employs approximately 3,000 individuals and has multiple customer service centers and offices throughout Denmark and one in New York. Its governance structure includes a Board of Directors with equal representation from employers and employees, along with an independent chairman.

Claus Berner Møller

Vice President

6 past transactions

DSV

Post in 2024
Founded in 1976 and headquartered in Denmark, DSV is a global transport and logistics company offering services by road, air, sea, and train. Its primary business comes from European trucking, airfreight forwarding, and sea freight forwarding.

MedTrace Pharma

Venture Round in 2023
MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Veo

Series C in 2022
Veo offers a camera-based system that records and streams sports matches without a traditional cameraman, requiring only minimal setup. It enables football clubs of all sizes to automatically capture, edit, and share their matches, using two action cameras that recognize ball and player movement to create full video productions. The solution aims to simplify video creation and provide affordable access to game footage and highlights.

MedTrace Pharma

Venture Round in 2021
MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Visiopharm

Venture Round in 2020
Visiopharm specializes in AI-based image analysis tools for the pathology industry. Founded in 2001, it offers end-to-end digital pathology solutions, including scanners and software with ready-to-use AI apps for diagnostic and research purposes. Its products are used globally by biopharmaceutical companies, CROs, hospitals, and academic institutions.

Visiopharm

Venture Round in 2018
Visiopharm specializes in AI-based image analysis tools for the pathology industry. Founded in 2001, it offers end-to-end digital pathology solutions, including scanners and software with ready-to-use AI apps for diagnostic and research purposes. Its products are used globally by biopharmaceutical companies, CROs, hospitals, and academic institutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.